Importer of Controlled Substances Application: VA Cooperative Studies Program, 33906-33907 [2023-11172]
Download as PDF
lotter on DSK11XQN23PROD with NOTICES1
33906
Federal Register / Vol. 88, No. 101 / Thursday, May 25, 2023 / Notices
Purpose of the Meeting: The Council
agenda will include:
INTERNATIONAL TRADE
COMMISSION
1. Minutes Review
2. Superintendent Updates will include:
General Management Plan
3. Resource Management Updates
4. Subcommittee Reports
5. Old Business
6. New Business
7. Public Comments
[Investigation Nos. 701–TA–565 and 731–
TA–1341 (Review)]
The meeting is open to the public.
Interested persons may make oral or
written presentations to the Council
during the business meeting or file
written statements. Requests to address
the Council should be made to the
Superintendent prior to the meeting.
Members of the public may submit
written comments by mailing them to
Derek Carter (see FOR FURTHER
INFORMATION CONTACT). All written
comments will be provided to members
of the Council. Due to time constraints
during the meeting, the Council is not
able to read written public comments
submitted into the record. Depending on
the number of people who wish to speak
and the time available, the time for
individual comments may be limited.
Meeting Accessibility/Special
Accommodations: The meeting is open
to the public. Please make requests in
advance for sign language interpreter
services, assistive listening devices, or
other reasonable accommodations. We
ask that you contact the person listed in
the FOR FURTHER INFORMATION CONTACT
section of this notice at least seven (7)
business days prior to the meeting to
give the Department of the Interior
sufficient time to process your request.
All reasonable accommodation requests
are managed on a case-by-case basis.
Public Disclosure of Comments:
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Authority: 5 U.S.C. ch. 10.
Alma Ripps,
Chief, Office of Policy.
[FR Doc. 2023–11210 Filed 5–24–23; 8:45 am]
BILLING CODE 4312–52–P
VerDate Sep<11>2014
18:04 May 24, 2023
Jkt 259001
Hardwood Plywood From China
Determination
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
antidumping and countervailing duty
orders on hardwood plywood from
China would be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
The Commission instituted these
reviews on December 1, 2022 (87 FR
73792) and determined on March 6,
2023 that it would conduct expedited
reviews (88 FR 19986, April 4, 2023).
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on May 19, 2023. The
views of the Commission are contained
in USITC Publication 5426 (May 2023),
entitled Hardwood Plywood from China:
Investigation Nos. 701–TA–565 and
731–TA–1341 (Review).
By order of the Commission.
Issued: May 19, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–11108 Filed 5–24–23; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1196]
Importer of Controlled Substances
Application: VA Cooperative Studies
Program
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
VA Cooperative Studies
Program has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
SUMMARY:
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before June 26, 2023. Such
persons may also file a written request
for a hearing on the application on or
before June 26, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on April 12, 2023, VA
Cooperative Studies Program, 2401
Centre Avenue SE, Albuquerque, New
Mexico 87106, applied to be registered
as an importer of the following basic
class(es) of controlled substance(s):
DATES:
Controlled substance
Marihuana Extract ...........
Tetrahydrocannabinols ....
Drug
code
Schedule
7350
7370
I
I
The company plans to import finished
dosage unit products containing the
above listed controlled substances for
research and clinical trial studies only.
No other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
E:\FR\FM\25MYN1.SGM
25MYN1
33907
Federal Register / Vol. 88, No. 101 / Thursday, May 25, 2023 / Notices
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Veranova, L.P. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 24, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
SUMMARY:
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–11172 Filed 5–24–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1193]
Bulk Manufacturer of Controlled
Substances Application: Veranova,
L.P.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 27, 2023,
Veranova, L.P., 2003 Nolte Drive, West
Deptford, New Jersey 08066–1727,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
lotter on DSK11XQN23PROD with NOTICES1
Gamma Hydroxybutyric Acid .........................................................................................................................................
Marihuana ......................................................................................................................................................................
Tetrahydrocannabinols ..................................................................................................................................................
Dihydromorphine ............................................................................................................................................................
Difenoxin ........................................................................................................................................................................
Amphetamine .................................................................................................................................................................
Methamphetamine .........................................................................................................................................................
Lisdexamfetamine ..........................................................................................................................................................
Methylphenidate .............................................................................................................................................................
Nabilone .........................................................................................................................................................................
4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ..................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) ................................................................................................
Cocaine ..........................................................................................................................................................................
Codeine ..........................................................................................................................................................................
Dihydrocodeine ..............................................................................................................................................................
Oxycodone .....................................................................................................................................................................
Dihydromorphine ............................................................................................................................................................
Hydromorphone .............................................................................................................................................................
Diphenoxylate ................................................................................................................................................................
Ecgonine ........................................................................................................................................................................
Hydrocodone ..................................................................................................................................................................
Levorphanol ...................................................................................................................................................................
Meperidine .....................................................................................................................................................................
Methadone .....................................................................................................................................................................
Methadone intermediate ................................................................................................................................................
Morphine ........................................................................................................................................................................
Thebaine ........................................................................................................................................................................
Opium tincture ...............................................................................................................................................................
Oxymorphone ................................................................................................................................................................
Noroxymorphone ...........................................................................................................................................................
Alfentanil ........................................................................................................................................................................
Remifentanil ...................................................................................................................................................................
Sufentanil .......................................................................................................................................................................
Tapentadol .....................................................................................................................................................................
Fentanyl .........................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates for sale to its customers.
In reference to drug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
18:04 May 24, 2023
Jkt 259001
PO 00000
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–11169 Filed 5–24–23; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
2010
7360
7370
9145
9168
1100
1105
1205
1724
7379
8333
8366
9041
9050
9120
9143
9145
9150
9170
9180
9193
9220
9230
9250
9254
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
Schedule
Frm 00048
Fmt 4703
Sfmt 9990
E:\FR\FM\25MYN1.SGM
25MYN1
Agencies
[Federal Register Volume 88, Number 101 (Thursday, May 25, 2023)]
[Notices]
[Pages 33906-33907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11172]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1196]
Importer of Controlled Substances Application: VA Cooperative
Studies Program
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: VA Cooperative Studies Program has applied to be registered as
an importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
June 26, 2023. Such persons may also file a written request for a
hearing on the application on or before June 26, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on April 12, 2023, VA Cooperative Studies Program, 2401
Centre Avenue SE, Albuquerque, New Mexico 87106, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Tetrahydrocannabinols................... 7370 I
------------------------------------------------------------------------
The company plans to import finished dosage unit products
containing the above listed controlled substances for research and
clinical trial studies only. No other activity for this drug code is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug
[[Page 33907]]
Administration-approved or non-approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-11172 Filed 5-24-23; 8:45 am]
BILLING CODE P